Overview

A Study to Assess the Effect of ASP1585 on Pharmacokinetics of Valsartan in Healthy Volunteers

Status:
Completed
Trial end date:
2010-04-01
Target enrollment:
Participant gender:
Summary
This study is to assess the effect of ASP1585 on pharmacokinetics of valsartan in 2x2 crossover method
Phase:
Phase 1
Details
Lead Sponsor:
Astellas Pharma Inc
Treatments:
Valsartan